Literature DB >> 9615206

25-year experience in the management of invasive bladder cancer by radical cystectomy.

D G Skinner1, J P Stein, G Lieskovsky, E C Skinner, S D Boyd, A Figueroa, P Jones, R Cote, S Groshen.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9615206     DOI： 10.1159/000052260

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  5 in total

1.  Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder.

Authors:  Christine L Chaffer; Bonnie Dopheide; Daniel R McCulloch; Allan B Lee; Jane M Moseley; Erik W Thompson; Elizabeth D Williams
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

2.  The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines.

Authors:  M J Seraj; M A Harding; J J Gildea; D R Welch; D Theodorescu
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 3.  Overview of Current and Future Adjuvant Therapy for Muscle-Invasive Urothelial Carcinoma.

Authors:  Rosa Nadal; Andrea B Apolo
Journal:  Curr Treat Options Oncol       Date:  2018-05-28

4.  The rationale for radical cystectomy as primary therapy for T4 bladder cancer.

Authors:  Udo Nagele; Aristotelis G Anastasiadis; Axel S Merseburger; Stefan Corvin; Jörg Hennenlotter; Melanie Adam; Karl-Dietrich Sievert; Arnulf Stenzl; Markus A Kuczyk
Journal:  World J Urol       Date:  2007-05-25       Impact factor: 4.226

5.  Surgical approach in patients with T4 bladder cancer as primary treatment: Disaster or option with improved quality of life.

Authors:  Udo Nagele; Aristotelis G Anastasiadis; Axel S Merseburger; Jörg Hennenlotter; Markus Horstmann; Karl-Dietrich Sievert; Arnulf Stenzl; Markus A Kuczyk
Journal:  Indian J Urol       Date:  2008-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.